Amicidins
TM
Our first new class of
macro biologics
Amicidins™
Macro's first class of proprietary macro biologics, Amicidins, are purpose-built for local application to vulnerable tissues to help prevent and treat life-threatening infections. Inspired by nature, they combine physical properties, like barrier formation, with broad microbicidal activity against a wide variety of bacteria (including antibiotic-resistant strains), as well as Candida spp. Importantly, Amicidins are composed of amino acids and designed to be safe for people and the environment.
The physical properties of Amicidins enable versatile product formulation and fabrication for diverse applications across multiple industries. These engineered macro biologics, alone and with excipients, can yield new products or improve existing ones. In healthcare, possibilities include breakthrough therapeutics, innovative medical devices, gentler veterinary & pet care products, and enhanced consumer health & cosmetic products. Development is currently underway to bring next-generation products to life to prevent and treat life-threatening infections, including those caused by antibiotic resistant microbes (see Pipeline).
Our two lead Amicidins, Amicidin-α and Amicidin-β, are already in four investigational products for the fields of surgery and trauma. Amicidin-α is the foundation for Amicidin-α Surgical and Amicidin-α PFC (Prolonged Field Care). Amicidin-β is the foundation for Amicidin-β Solution and Amicidin-β/EF (Extended Formulation; see Pipeline).
Looking to the future, single Amicidins are expected to yield multiple distinct products with diverse applications -- in some cases, across multiple industries. To learn more about corporate partnering opportunities, see Partnering.